UroGen Pharma Ltd. (URGN)
43.61
-1.89
(-4.15%)
USD |
NASDAQ |
Aug 28, 16:00
43.61
0.00 (0.00%)
After-Hours: 20:00
UroGen Pharma Shareholders Equity (Quarterly) : -132.40M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -132.40M |
| March 31, 2026 | -124.25M |
| December 31, 2025 | -105.47M |
| September 30, 2025 | -115.41M |
| June 30, 2025 | -93.38M |
| March 31, 2025 | -46.46M |
| December 31, 2024 | -8.803M |
| September 30, 2024 | 25.52M |
| June 30, 2024 | 30.31M |
| March 31, 2024 | -40.13M |
| December 31, 2023 | -65.21M |
| September 30, 2023 | -41.99M |
| June 30, 2023 | -138.43M |
| March 31, 2023 | -116.55M |
| December 31, 2022 | -89.36M |
| September 30, 2022 | -63.29M |
| June 30, 2022 | -40.91M |
| March 31, 2022 | -17.07M |
| December 31, 2021 | 8.413M |
| Date | Value |
|---|---|
| September 30, 2021 | 31.54M |
| June 30, 2021 | 56.27M |
| March 31, 2021 | 76.49M |
| December 31, 2020 | 96.36M |
| September 30, 2020 | 120.53M |
| June 30, 2020 | 142.66M |
| March 31, 2020 | 150.45M |
| December 31, 2019 | 180.30M |
| September 30, 2019 | 210.92M |
| June 30, 2019 | 224.78M |
| March 31, 2019 | 239.59M |
| December 31, 2018 | 90.09M |
| September 30, 2018 | 103.58M |
| June 30, 2018 | 113.55M |
| March 31, 2018 | 123.87M |
| December 31, 2017 | 68.52M |
| September 30, 2017 | 76.26M |
| June 30, 2017 | 74.07M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Insmed, Inc. | 757.49M |
| Xencor, Inc. | 503.23M |
| MeiraGTx Holdings Plc | 215.57M |
| IDEAYA Biosciences, Inc. | 1.199B |
| ACADIA Pharmaceuticals, Inc. | 1.307B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 252.59M |
| Total Liabilities (Quarterly) | 384.99M |
| Debt to Equity Ratio | -1.481 |
| Current Ratio | 3.802 |
| Net Debt Paydown Yield | -0.78% |